Fas-independent cytotoxicity mediated by human CD4+ CTL directed against herpes simplex virus-infected cells

Journal of Immunology

Volumn 162, Issue 10, 1999, Pages 6100-6106

  Yasukawa, Masaki ^a   Ohminami, Hideki ^a   Yakushijin, Yoshihiro ^a   Arai, Junko ^a   Hasegawa, Atsuhiko ^a   Ishida, Yasushi ^a   Fujita, Shigeru ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CD4 ANTIGEN; CONCANAMYCIN A; FAS ANTIGEN; FAS LIGAND; GRANZYME B; HLA ANTIGEN CLASS 2; MESSENGER RNA; PERFORIN;

ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; FEMALE; GENE MUTATION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; PRIORITY JOURNAL; VIRUS INFECTION;

EID: 0033562990     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Kägi, D., F. Vignaux, B. Ledermann, K. Burki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528.
2. Lowin, B., M. Hahne, C. Mattmann, and J. Tschopp. 1994 Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370: 650.
3. Walsh, C. M., M. Matloubian, C.-C. Liu, R. Ueda, C. G. Kurahara, J. L. Christensen, M. T. F. Huang, J. D.-E. Young, R. Ahmed, and W. R. Clark. 1994. Immune function in mice lacking the perforin gene. Proc. Natl. Acad. Sci. USA 91:10854.
4. Kojima, H., N. Shinohara, S. Hanaoka, Y. Someya-Shirota, Y. Takagaki, H. Ohno, T. Saito, T. Katayama, H. Yagita, K. Okumura, Y. Shinkai, F. W. Alt, A. Matsuzawa, S. Yonehara, and H. Takayama. 1994. Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity 1:357.
5. Henkart, P. A. 1994. Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity 1:343.
6. Kägi, D., B. Ledermann, K. Bürki, R. M. Zinkernagel, and H. Hengartner. 1996. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 14:207.
7. Tschopp, J., and M. Nabholz. 1990. Perforin-mediated target cell lysis by cytotoxic T lymphocytes. Annu. Rev. Immunol. 8:279.
8. Ramsdell, F., M. S. Seaman, R. E. Miller, T. W. Tough, M. R. Alderson, and D. H. Lynch. 1994. gld/gld mice are unable to express a functional ligand for Fas. Eur. J. Immunol. 24:928.
9. Kägi, D., B. Ledermann, K. Bürki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31.
10. Hanabuchi. S., M. Koyanagi, A. Kawasaki, N. Shinohara, A. Matsuzawa, Y. Nishimura, Y. Kobayashi, S. Yonehara, H. Yagita, and K. Okumura. 1994. Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity. Proc. Natl. Acad. Sci. USA 91:4930.
11. + T cell-mediated cytotoxicity. J. Immunol 152:1127.
12. + cytotoxic T cells. Proc. Natl. Acad Sci. USA 91:4185.
13. Rieux-Laûcal, F. R., F. L. Deist, C. Hivroz, I. A. G. Roberts, K. M. Debatin, A. Fischer, and J. P. de Villartay. 1995. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347.
14. Fisher, G. H., F. J. Rosenberg, S. E. Straus, J. K. Dale, L. A. Middelton, A. Y. Lin, W. Strober, M. J. Lenardo, and J. M. Puck. 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935.
15. Nagata, S. 1998. Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: a lesson from the mouse model. J. Hum. Genet. 43:2.
16. Yasukawa, M., and J. M. Zarling. 1984. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens. J. Immunol. 133:422.
17. Schmid, D. S., and B. T. Rouse. 1992. The role of T cell immunity in control of herpes simplex virus. Curr. Top. Microbiol. Immunol. 179:57.
18. Hill, A. B., B. C. Barnett, A. J. McMichael, and D. J. McGeoch. 1994. HLA class I molecules are not transported to the cell surface in cells infected with herpes simplex virus types 1 and 2. J. Immunol 152:2736.
19. + T lymphocytes. Cell 77:525.
20. Kasahara, Y., T. Wada, Y. Niida, A. Yachie, H. Seki, Y. Ishida, T. Sakai, F. Koizumi, S. Koizumi, T. Miyawaki, and N. Taniguchi. 1998. Novel Fas (CD95/APO-1 ) mutations in infants with a lymphoproliferative disorder. Int. Immunol. 10:195.
21. + T cells. J. Immunol. 146:1341.
22. + human cytotoxic T cell clones directed against herpes simplex virus. J. Immunol. 140:3419.
23. Takayama, H., N. Shinohara, A. Kawasaki, Y. Someya, S. Hanaoka, H. Kojima, H. Yagita, K. Okumura, and Y. Shinkai. 1991. Antigen-specific directional target cell lysis by perforin-negative T lymphocyte clones. Int. Immunol. 3:1149.
24. Carding, S. R., D. Lu, and K. Bottomly. 1992. A polymerase chain reaction assay for the detection and quantitation of cytokine gene expression in small numbers of cells. J. Immunol. Methods 151:277.
25. Yasukawa, M., and J. M. Zarling. 1983. Autologous herpes simplex virus-infected cells are lysed by human natural killer cells. J. Immunol. 131:2011.
26. + human cytotoxic T cell clones. Clin. Immunol. Immunopathol. 78:70.
27. Kataoka, T., N. Shinohara, H. Takamiya, K. Takaku, S. Kondo, S. Yonehara, and K. Nagai. 1996. Concanamycin A, a powerful tool for characterization and estimation of contribution of perform-and Fas-based lytic pathways in cell-mediated cytotoxicity. J. Immunol. 156:3678.
28. Jerome, K. R., J. F. Tait, D. M. Koelle, and L. Corey. 1998. Herpes simplex virus type 1 renders infected cells resistant to cytotoxic T-lymphocyte-induced apoptosis. J. Virol. 72:436.
29. 2+-independent T cell-mediated cytotoxicity. J. Exp. Med. 177:195.
30. Lowin, B., C. Madman, M. Hahne, and J. Tschopp. 1996. Comparison of Fas (Apo-1/CD95)-and perforin-mediated cytotoxicity in primary T lymphocytes. Int. Immunol. 8:57.
31. + T cell clones use perform-or Fas/Fas ligand-mediated pathways for target cell lysis. J. Immunol. 158:2756.
32. Thomas, W. D., and P. Hersey. 1998. CD4 T cells kill melanoma cells by mechanisms that are independent of Fas (CD95). Int. J. Cancer 75:384.
33. Esser, M. T., B. Krishnamurthy, and V. L. Braciale. 1996. Distinct T cell receptor signaling requirements for perforin-or FasL-mediated cytotoxicity. J. Exp. Med. 183:1697.
34. Ando, K., K. Hiroishi, T. Kaneko, T. Moriyama, Y. Muto, N. Kayagaki, H. Yagita, K. Okumura, and M. Imawari. 1997. Perforin, Fas/Fas ligand, and TNF-α pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL. J. Immunol. 158:5283.
35. + T cells. J. Exp. Med. 171:1269.
36. + human T-cell clones. J. Virol. 66:2773.
37. + human cytotoxic T-cell clones. Blood 81:1527.
38. + human CTL clones induced by candidate AIDS vaccines. J. Immunol. 153:2787.
39. Braakman, E., F. T. M. Rotteveel, O. van Bleek, G. A. van Seventer, and C. J. Lucas. 1987. Are MHC class II-restricted cytotoxic T lymphocytes important? Immunol. Today 8:265.
40. Kuzushima, K., K. Isobe, T. Morishima, A. Takatsuki, and I. Nakashima. 1990. Inhibitory effect of herpes simplex virus infection to target cells on recognition of minor histocompatibility antigens by cytotoxic T lymphocytes. J. Immunol. 144: 4536.
41. Koelle, D. M., H. Abbo, A. Peck, K. Ziegweid, and L. Corey. 1994. Direct recovery of herpes simplex virus (HSV)-specific T lymphocyte clones from recurrent genital HSV-2 lesions. J. Infect. Dis. 169:956.
42. + T cells in corneas of herpetic stromal keratitis patients. J. Infect. Dis. 177:484.
43. Ito, M., W. Koide, M. Watanabe, H. Kamiya, and M. Sakurai. 1997. Apoptosis of cord blood T lymphocytes by herpes simplex virus type 1. J. Gen. Virol. 78:1971.